INSIGHTS ON CLINICAL TRIAL DESIGN
-
Decentralized And Community-Based Solutions Driving Women's Healthcare
Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.
-
The Implications Of Semaglutide's Connect To Increased Risk Of NAION
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution
Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.
-
When Should You Rescue Your Clinical Trial From A Bad RTSM?
Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.
-
How Pharmaceutical Companies Can Effectively Engage With PAOs2/11/2025
Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.
-
Sleep Assessment In Sleep Disorders3/16/2026
Discover how continuous, objective monitoring in a home environment captures sleep improvements that traditional lab-based snapshots often miss, ensuring more accurate clinical outcomes.
-
Clinical Trial Recruitment Strategies For Rare Disease Studies7/20/2026
By deploying mobile clinics equipped with specialized diagnostic tools and trained technicians, sponsors can execute protocol-adherent assessments right in the participant's community.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Rare Disease R&D: Continued Growth Amid Challenges3/21/2025
The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
At Avance Clinical, patients are our priority. We meticulously select experienced sites and clinics, alongside patient advocacy groups and communities to ensure optimal patient care and outcomes.
-
Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.
-
Obtain smarter, faster, and more resilient clinical trials that reduce cost, improve outcomes, and bring life-changing therapies to patients sooner with integrated, user-friendly technology.